 |
 Play Video: The Importance of Insider Buying
|
|
|
| Date | Insider | Price | Amount |
|---|
6-7-2023
Insider Buy |
Shawn McCormick
|
$22.88
CAGR »
|
$171,633.00
7,500 shares |
5-9-2022
Insider Buy |
Kashif Rashid
General Counsel |
$44.50
CAGR »
|
$100,126.12
2,250 shares |
3-11-2022
Insider Buy |
Kashif Rashid
General Counsel |
$64.04
CAGR »
|
$96,067.20
1,500 shares |
12-14-2021
Insider Buy |
Kevin C. Oboyle
Director |
$83.78
CAGR »
|
$201,070.00
2,400 shares |
11-22-2021
Insider Buy |
Elizabeth H. Weatherman
Director |
$85.33
CAGR »
|
$1,706,548.33
20,000 shares |
11-11-2021
Insider Buy |
Kashif Rashid
General Counsel |
$101.05
CAGR »
|
$202,100.00
2,000 shares |
6-7-2019
Insider Buy |
Elizabeth H. Weatherman
Director |
$61.22
CAGR »
|
$500,981.42
8,183 shares |
6-5-2019
Insider Buy |
Kevin C. Oboyle
Director |
$60.00
CAGR »
|
$100,500.00
1,675 shares |
11-13-2015
Insider Buy |
Brad Vale
Director |
$50.76
CAGR »
|
$101,520.00
2,000 shares |
11-12-2014
Insider Buy |
A/S Novo
>10% Owner |
$18.00
CAGR »
|
$3,870,000.00
215,000 shares |
11-12-2014
Insider Buy |
& Johnson Johnson
>10% Owner |
$18.00
CAGR »
|
$720,000.00
40,000 shares |
Also See: Institutional Holders of NVRO
Also See: SEC filings
Below we present the annualized performance delivered by Nevro stock since 6-7-2023 (the date of the most recent
insider purchase). The performance of the investment from the time Nevro insider buying occurred is the ultimate
test of whether insiders were right about NVRO being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
06/08/2023 |
|
| End date: |
04/24/2024 |
|
| Start price/share: |
$23.60 |
|
| End price/share: |
$12.51 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-46.99% |
|
| Annualized Gain: |
-53.43% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$5,301.00 |
|
| Years: |
0.88 |
|
Nevro Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent Nevro insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding NVRO
|
|
Free NVRO Email Alerts:
